Summary.-Prior splenectomy increased the resistance of BALB/c mice to a syngeneic methylcholanthrene-induced ascitic tumour inoculated i.p. The survival rate of splenectomized mice was 81-60/ while those of normal and sham-operated controls were 11.5%O and 20% respectively. The effect of splenectomy, however, was seen only within the dose range of 103 to 104 tumour cells. This effect of splenectomy was abolished by the transfer to mice of serum from tumour-bearing mice, and of spleen cells from normal donors, immediately after the inoculation of tumour cells. Cellfree ascitic fluid did not abolish the effect of splenectomy. The findings suggest that there is a subpopulation of spleen cells which produces a tumour growth enhancing factor which is found in the serum of tumour-bearing mice.
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IN recent years, various investigators
have shown a renewed interest in the role of the spleen in the immune response to tumours, as the spleen is a relatively rare site for metastases when compared to the rest of the reticulo-endothelial system (Willis, 1973) . In vivo experiments to examine the effect of splenectomy on the behaviour of tumours used several different criteria. Thus various workers have examined the effect of splenectomy on (a) the incidence of spontaneously arising tumours (Whitmore, Salerno and Rabstein, 1972; Check et al., 1974) ; (b) the induction of tumours by chemical carcinogens (Cohen, Headley and Bryan, 1973; Akamatsu, 1975 ); (c) the incidence of spontaneouis regression of tumours (Pollack, 1971; Ferrer and Mihich, 1968) ; and (d) the behaviour of transplanted tumours (Moller, 1965; Sjogren, 1973, 1974) . The results of these investigations suggest that although splenectomy has no effect on the incidence of spointaneous tumours, or oni the induction of tumours by chemical carcinogens, it reduces the rate of growth of transplanted tumours, and may increase the incidence of spontaneous regression of tumours. However, several criticisms may be made of these reports. The behaviour of transplanted tumours has been followed by measurement of the size of the tumour nodule, a parameter whose significance is difficult to interpret. Furthermore, the effect of splenectomy on the survival of animals with transplanted tumours has not been reported, or has found to be negligible.
Using survival as the criterion, we present evidence here that prior splenectomy increases the host resistance to a transplanted tumour. We have also followed the behaviour of the transplanted tumour, by determining the rate of ascites formation and also bv tumour cell counts. Spleen-cell suspensions.-Spleens removed from mice killed by cervical dislocation were crushed gently in ice-cold PBS with a glass rod in glass centrifuge tubes. Tissue clumps were allowed to settle and the cell suspension removed. It was washed once with PBS and centrifuged at 250 g for 10 min. Red cells were lysed by hypotonic shock as follows: the spleen cell pellet was resuspended in 1 ml of PBS, about 4 ml of sterile water was added, and the suspension stirred with a Pasteur pipette for 5 s, when 6 ml of PBS was added. The suspension of spleen cells was then washed for 5 min and resuspended in PBS.
Viability as determined by trypan blue exclusion was usually more than 80%.
Mouse serum.-Mice were bled by division of the thoracic part of the inferior vena cava under ether anaesthesia, and the serum was separated out by centrifugation after clotting. Serum from tumour-bearing mice was obtained from donors that had received 103 MCA tumour cells i.p. 2 weeks previously.
Cell-free ascitic fluid.-Ascitic fluid containing tumour cells, obtained by tapping the abdominal cavities of tumour-bearing animals that had received 103 tumour cells i.p. 2 weeks previously, was spun twice at 500 g for 10 min. The supernatant fluid was removed, and examined under the microscope to check that it was free of cells.
Determination of survival rates and mean time of death of tumour-bearing mice.-The fate of all test and control animals was followed for at least 50 days after tumour inoculation: some mice were kept for more than 270 days. The survival rate and mean time of death were calculated. The data presented here are usually the pooled results of several experiments.
Rate offormation of ascites.-All mice were individually marked and weighed on the first day of the experiment, so that the change in weight of each animal could be recorded. The average weight of each group of animals on various days was determined and expressed as a percentage of the average weight of the group on Day 0. The animals were usually weighed every 3 to 5 days, but more often when ascites formation was rapid.
A preliminary experiment was performed to check that the natural gain in weight of the animals was of an order that would not invalidate this method of estimation of the rate of formation of ascites. The rate of gain in weight of 10 mice was recorded from the day they were born until they were 22 weeks old. The gain in weight reached a nearplateau at about 7 weeks, after which the gain in weight was 2% per week. Animals with ascitic tumour gained about 3000 in weight per week. The animals that succumbed to the ascitic tumour usually died before showing signs of malignant cachexia. The weight of dead animals drained of their ascitic fluid was usually within 2 g of their original weight.
Growth rate of tumour cells. A rather surprising finding was that the survival rate for the splenectomized group was not much better than that for normal and sham-operated animals given 102 tumour cells (0.1 < P < 0 2).
The mean time of death (MTD) of the 3 groups of animals was compared (Fig. 2 ).
There was no difference between the MTDs of the animals that died from the tumour in all 3 groups.
Rate of formation of ascites
The rate of formation of ascites for each of the 3 groups was determined for mice given 103 tumour cells (Fig. 3) . There was a rapid increase in the weight and, presumably, the amount of ascites formed, in normal and sham-operated mice from Day 12. These animals began to die when their weight reached more than 130% of their original weight. Splenectomized mice, however, gained relatively little in weight. thereafter, but at a much slower rate. The presence in serum from tumourbearing mice of blocking factors which enhance the growth of tumour has been reported by many workers (Hellstrom, Hellstrom and Sjogren, 1970; Sjogren et al., 1971) . So the possibility that the effect of splenectomy may be reversed by the transfer of serum from tumour-bearing mice was tested. Serum obtained from tumour-bearing mice was diluted 1/2 and used immediately; 0 1-ml volumes were given i.p. to splenectomized mice that had just received 103 tumour cells by the same route.
One control group of mice received 0 1-ml volumes of normal serum similarly diluted 1/2. A second group of splenectomized animals received tumour cells alone. Since it was possible that ascitic fluid from tumour-bearing animals might also contain blocking factors, a fourth group of splenectomized animals was given cell-free ascitic fluid in addition to tumnour cells. Serum from tumour-bearing mice reversed the protective effect of splenectomy (Fig. 6) . Normal serum and cell-free ascitic fluid had no effect.
DISCUSSION
The most striking finding of this study is that splenectomized BALB/c mice were protected from death caused by the growth of a methylcholanthrene-induced ascitic tumour inoculated i.p. The The protective effect of splenectomy was seen only within a fairly narrow range of tumour cell dose: 103 to 104 cells. This suggests that within this dose range, the host-tumour relationship is finely balanced and that it may be tipped in favour of the host if the tumour-growth-enhancing cells are removed by splenectomy.
A possible implication of the present observation is that incidental splenectomy during the surgical resection of carcinoma of the stomach or colon may affect the long term prognosis in these patients. It would be of interest to conduct a survey to see if this is the case.
The model described in this investigation demonstrated a protective effect of splenectomy performed before the establishment of the tumour, a procedure which could not be used therapeutically. Therefore one of the most obvious lines for future investigation would be to see if splenectomy performed after the introduction of a tumour can protect the host.
A second observation concerning the dose-dependent effect of splenectomy was that there was little difference among the survival rates of splenectomized, normal and sham-operated mice given 102 tumour cells. Norlund and Gershon (1975) reported a similar finding. They transplanted a syngeneic murine melanoma (Cloudman S91) to DBA/2 mice, and found that tumours appeared earlier in splenectomized animals than in normal animals when a small tumour inoculum (104 cells) was used. The converse happened with a larger tumour inoculum (106 cells). They suggested that the immunosuppressive effect of the spleen with larger amounts of antigen was due to the stimulation of suppressor T cells. They offered no explanation for the immunopotentiating role of the spleen with smaller amounts of antigen. Perhaps splenic suppressor T cells or enhancing antibody-producing cells are not stimulated by a small antigenic load. Serum from tumour-bearing animals abolished the protective effect of splenectomy. Biddle (1976) has recently reported similar findings using BI x C3H mice and a syngeneic methylcholanthrene-induced tumour. He showed that serum from tumour-bearing mice, when mixed with specific tumour cells before inoculation into syngeneic recipients that had been crippled immunologically by adult thymectomy and whole-body irradiation, was able to enhance the growth of transplanted tumour, as measured by the size of the subcutaneous nodule 6 weeks later. This enhancing effect was absorbed by incubation with specific tumour cells.
There have been many reports documenting the presence of blocking factors in sera from tumour-bearing animals. Hellstrom et al. (1970) reported that serum from tumour-bearing BALB/c mice inhibited the cellular response of lymphnode cells to a syngeneic methylcholanthrene-induced tumour, as demonstrated by the colony inhibition assay. They also found that there was less blocking activity in serum obtained from tumour-bearing mice that had been splenectomized. Sjogren et al. (1971) provided evidence that suggested that the blocking factors were antigen-antibody complexes. Bowen, Robins and Baldwin (1975) also demonstrated the presence of blocking antigenantibody complexes in serum obtained from rats bearing the rat hepatoma D23.
The inability of cell-free ascitic fluid to reverse the protective effect of splenectomy was unexpected, as it was thought to .5.1 be a likely source of blockinig factors. However, it is possible that since ascitic fluid bathes millions of tumour cells in the peritoneal cavity of the tumour-bearing mice, the blocking factors will have adsorbed to the surface of those cells.
The adsorption of serum blocking factors by incubation with specific tumour cells has recently been reported (Biddle, 1976) .
Our findings therefore suggests that there is a subpopulation of spleen cells which produces a tumour-growth-enhancing factor that is found in the serum of tumour-bearing mice. The characterization of the cell population involved will be the subject of a further communication. In addition it is planned to characterize the serum factor, particularly with respect to its specificity and chemical relation to immunoglobulin.
